{"title":"通过对双盲、随机对照试验的荟萃分析,对未发现心血管疾病但有心血管危险因素的人进行长期使用他汀类药物的益处(或:风险降低)","authors":"E. V. Does","doi":"10.1007/BF03080039","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"140-141"},"PeriodicalIF":0.0000,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03080039","citationCount":"0","resultStr":"{\"title\":\"De voordelen van (of: de risicovermindering door) langetermijn statinegebruik bij mensen zonder vastgestelde cardiovasculaire ziekte, maar met cardiovasculaire risicofactoren via een meta-analyse van verricht dubbelblind, gerandomiseerd gecontroleerd onderzoek\",\"authors\":\"E. V. Does\",\"doi\":\"10.1007/BF03080039\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":92937,\"journal\":{\"name\":\"Medisch-farmaceutische mededelingen\",\"volume\":\"47 1\",\"pages\":\"140-141\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/BF03080039\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medisch-farmaceutische mededelingen\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/BF03080039\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medisch-farmaceutische mededelingen","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03080039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
De voordelen van (of: de risicovermindering door) langetermijn statinegebruik bij mensen zonder vastgestelde cardiovasculaire ziekte, maar met cardiovasculaire risicofactoren via een meta-analyse van verricht dubbelblind, gerandomiseerd gecontroleerd onderzoek